| High performance plasma amyloid-β biomarkers for Alzheimer’s disease A Nakamura, N Kaneko, VL Villemagne, T Kato, J Doecke, V Doré, ... Nature 554 (7691), 249-254, 2018 | 1683 | 2018 |
| Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial JR Biesiekierski, ED Newnham, PM Irving, JS Barrett, M Haines, ... Official journal of the American College of Gastroenterology| ACG 106 (3 …, 2011 | 1101 | 2011 |
| Blood-based protein biomarkers for diagnosis of Alzheimer disease JD Doecke, SM Laws, NG Faux, W Wilson, SC Burnham, CP Lam, ... Archives of neurology 69 (10), 1318-1325, 2012 | 492 | 2012 |
| Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment L Cheng, JD Doecke, RA Sharples, VL Villemagne, CJ Fowler, ... Molecular psychiatry 20 (10), 1188-1196, 2015 | 413 | 2015 |
| A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes RC Ferreira, H Guo, RMR Coulson, DJ Smyth, ML Pekalski, OS Burren, ... Diabetes 63 (7), 2538-2550, 2014 | 331 | 2014 |
| Reduced α-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn’s disease LA Simms, JD Doecke, MD Walsh, N Huang, EV Fowler, ... Gut 57 (7), 903-910, 2008 | 322 | 2008 |
| Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline S Ayton, A Fazlollahi, P Bourgeat, P Raniga, A Ng, YY Lim, I Diouf, ... Brain 140 (8), 2112-2119, 2017 | 276 | 2017 |
| Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals N Fandos, V Pérez-Grijalba, P Pesini, S Olmos, M Bossa, VL Villemagne, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 8, 179-187, 2017 | 210 | 2017 |
| Biochemically-defined pools of amyloid-β in sporadic Alzheimer’s disease: correlation with amyloid PET BR Roberts, M Lind, AZ Wagen, A Rembach, T Frugier, QX Li, TM Ryan, ... Brain 140 (5), 1486-1498, 2017 | 157 | 2017 |
| Total Aβ42/Aβ40 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis JD Doecke, V Pérez-Grijalba, N Fandos, C Fowler, VL Villemagne, ... Neurology 94 (15), e1580-e1591, 2020 | 155 | 2020 |
| Meta-analysis of serum non-ceruloplasmin copper in Alzheimer's disease R Squitti, I Simonelli, M Ventriglia, M Siotto, P Pasqualetti, A Rembach, ... Journal of Alzheimer’s disease 38 (4), 809-822, 2013 | 145 | 2013 |
| Alzheimer’s disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies—gains from AIBL and DIAN cohort studies RN Martins, V Villemagne, HR Sohrabi, P Chatterjee, TM Shah, G Verdile, ... Journal of Alzheimer’s Disease 62 (3), 965-992, 2018 | 143 | 2018 |
| A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study SC Burnham, NG Faux, W Wilson, SM Laws, D Ames, J Bedo, AI Bush, ... Molecular psychiatry 19 (4), 519-526, 2014 | 136 | 2014 |
| Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: a cross‐sectional and longitudinal study in the AIBL cohort P Chatterjee, S Pedrini, JD Doecke, R Thota, VL Villemagne, V Doré, ... Alzheimer's & Dementia 19 (4), 1117-1134, 2023 | 135 | 2023 |
| Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte‐derived monocyte chemotaxis protein‐1 in hepatic stellate cell recruitment GA Ramm, RW Shepherd, AC Hoskins, SA Greco, AD Ney, TN Pereira, ... Hepatology 49 (2), 533-544, 2009 | 127 | 2009 |
| Fifteen years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) study: progress and observations from 2,359 older adults spanning the spectrum from cognitive normality … C Fowler, SR Rainey-Smith, S Bird, J Bomke, P Bourgeat, BM Brown, ... Journal of Alzheimer's disease reports 5 (1), 443-468, 2021 | 115 | 2021 |
| ATG16L1 T300A shows strong associations with disease subgroups in a large Australian IBD population: further support for significant disease heterogeneity EV Fowler, J Doecke, LA Simms, ZZ Zhao, PM Webb, NK Hayward, ... Official journal of the American College of Gastroenterology| ACG 103 (10 …, 2008 | 114 | 2008 |
| An increased neutrophil–lymphocyte ratio in Alzheimer's disease is a function of age and is weakly correlated with neocortical amyloid accumulation A Rembach, AD Watt, WJ Wilson, S Rainey-Smith, KA Ellis, CC Rowe, ... Journal of neuroimmunology 273 (1-2), 65-71, 2014 | 110 | 2014 |
| Outcomes of salvage therapy for steroid‐refractory acute severe ulcerative colitis: ciclosporin vs. infliximab A Croft, A Walsh, J Doecke, R Cooley, M Howlett, G Radford‐Smith Alimentary pharmacology & therapeutics 38 (3), 294-302, 2013 | 105 | 2013 |
| Pregabalin in severe burn injury pain: a double-blind, randomised placebo-controlled trial P Gray, J Kirby, MT Smith, PJ Cabot, B Williams, J Doecke, T Cramond Pain 152 (6), 1279-1288, 2011 | 104 | 2011 |